Glaxosmithkline Phar
NSE
₹ 0.00
0.00 (0.00)%
Mid-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
18 05 2021 | Dividend & Audited Results |
26 07 2021 | Quarterly Results |
29 10 2021 | Quarterly Results |
07 02 2022 | Quarterly Results |
16 05 2022 | Audited Results & Dividend |
25 07 2022 | Quarterly Results |
11 11 2022 | Quarterly Results |
07 02 2023 | Quarterly Results |
17 05 2023 | Final Dividend & Audited Results |
26 07 2023 | Quarterly Results |
09 11 2023 | Quarterly Results |
12 02 2024 | Quarterly Results |
29 10 2024 | Interim Dividend & Quarterly Results |
10 02 2025 | Quarterly Results(Cancelled) (Cancelled) |
10 02 2025 | Quarterly Results |
14 02 2025 | Quarterly Results |
No News data available